Central Alerting System
View Alert

Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 25-Jun-2021 08:30:07

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Specialists Trusts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ofsted recipients
  • Ambulance Trusts
  • Social Care Providers (registered with CAS)
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Mental Health & Learning Disabilities Trusts
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Director of Public Health
  • Acute Trusts
  • Community Trusts
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Dexamethasone 0.1% (Maxidex) 5ml eye drops

Broadcast content:

There are limited supplies of preserved dexamethasone (Maxidex®) 0.1% eye drops in a multi-dose container until early August 2021 due to a manufacturing issue.  During this period stock will only be available to order directly from Novartis and subject to order limits.

Dexamethasone 0.1% preservative free and alternative steroid eye drops remain available in single dose and multi-dose containers and collectively can support an uplift in demand.

For patients with insufficient supplies until the resupply date, clinicians should consider prescribing an alternative preparation as appropriate.

Patients who are on long term treatment should be fully counselled if switched to alternative preparations, particularly preservative free single dose preparations, due to the need to dispose of the unit dose after use. 

This alert contains further information and action for providers.

Please note that no response is required via the CAS website to this alert.

Additional information: NHS England and NHS Improvement Regional Offices: please cascade this alert to community pharmacy and optometry contractors.

Alert reference: SDA/2021/007


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency